Fig. 5From: Patient-reported experience with Fabry disease and its management in the real-world setting: results from a double-blind, cross-sectional survey of 280 respondentsSymptoms reported by respondents who experienced symptom worsening between ERT infusions (N = 122). ERT, enzyme replacement therapyBack to article page